Fore Capital, LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 43 filers reported holding SECOND SIGHT MED PRODS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Fore Capital, LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2019$42,000
-8.7%
56,3000.0%0.01%
+133.3%
Q3 2019$46,000
+2.2%
56,3000.0%0.00%
-57.1%
Q2 2019$45,000
-50.0%
56,300
-50.0%
0.01%
+16.7%
Q1 2019$90,000
+80.0%
112,600
+100.0%
0.01%
-76.0%
Q4 2018$50,000
-34.2%
56,300
+40.8%
0.02%
+8.7%
Q3 2018$76,00040,0000.02%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,492,975$8,536,653,0002.90%
Glassman Wealth Services 72,366$137,0000.06%
B. Riley Wealth Management, Inc. 53,500$102,0000.02%
Sigma Planning Corp 223,400$424,0000.02%
Fore Capital, LLC 40,000$76,0000.02%
Psagot Value Holdings Ltd. 218,555$415,0000.02%
HBK Sorce Advisory LLC 85,500$162,0000.02%
WealthTrust Axiom LLC 10,000$19,0000.01%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 12,894$24,0000.01%
Weiss Asset Management LP 29,691$56,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders